Mon, Sep 15, 2025
[Archive]
Volume 15, Issue 4 (9-2025)
Iran J Ped Hematol Oncol 2025, 15(4): 637-646 |
Back to browse issues page
Ethics code: IR.AJUMS.REC.1397.957
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Keikhaei B, Kalantarfard N, Mahmoudian-Sani M R. Challenges and Developments in Prenatal Diagnosis of Beta-Thalassemia: A Study on Diagnostic Accuracy. Iran J Ped Hematol Oncol 2025; 15 (4) :637-646
URL: http://ijpho.ssu.ac.ir/article-1-922-en.html
URL: http://ijpho.ssu.ac.ir/article-1-922-en.html
Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Abstract: (13 Views)
Background: Beta-thalassemia major is prevalent in areas like Khuzestan, Iran, and causes severe anemia requiring lifelong treatment. Despite successful prevention programs, diagnostic errors in Prenatal Diagnosis (PND) persist, leading to affected births. This study evaluates the accuracy of PND, identifies the causes of errors, and suggests improvements to diagnostic protocols.
Materials and Methods: A retrospective descriptive cross-sectional study (2012–2018) with 202 beta-thalassemia carrier couples from Shafa Hospital, Ahvaz, Iran. Fetal DNA analysis was conducted via Chorionic Villus Sampling (CVS) and amniotic fluid sampling using Amplification Refractory Mutation System Polymerase Chain Reaction (ARMS-PCR), Gap Polymerase Chain Reaction (Gap-PCR), and sequencing. Statistical analysis results revealed factors influencing diagnostic errors.
Results: Affected infants were diagnosed with beta-thalassemia major at an average age of five months. The results showed six diagnostic errors (2.14%), primarily associated with point mutations. Errors occurred more frequently in amniotic fluid sampling (4.05%) than in CVS sampling (1.45%). CD 36/37, IVS-II-1, and Fr8–9 were the most common detected mutations.
Conclusion: Improving the accuracy of PND for beta-thalassemia is crucial, particularly in regions with high prevalence, such as Khuzestan, Iran. Although the overall diagnostic error rate was low (2.14%), the consequences of such errors are significant. The diagnostic error can lead to the birth of affected children and an added burden on families and healthcare systems. Most errors were linked to point mutations and were more frequent in amniotic fluid sampling than in CVS. To minimize such diagnostic mistakes, advancements in molecular diagnostic techniques—especially for detecting rare mutations—are necessary.
Materials and Methods: A retrospective descriptive cross-sectional study (2012–2018) with 202 beta-thalassemia carrier couples from Shafa Hospital, Ahvaz, Iran. Fetal DNA analysis was conducted via Chorionic Villus Sampling (CVS) and amniotic fluid sampling using Amplification Refractory Mutation System Polymerase Chain Reaction (ARMS-PCR), Gap Polymerase Chain Reaction (Gap-PCR), and sequencing. Statistical analysis results revealed factors influencing diagnostic errors.
Results: Affected infants were diagnosed with beta-thalassemia major at an average age of five months. The results showed six diagnostic errors (2.14%), primarily associated with point mutations. Errors occurred more frequently in amniotic fluid sampling (4.05%) than in CVS sampling (1.45%). CD 36/37, IVS-II-1, and Fr8–9 were the most common detected mutations.
Conclusion: Improving the accuracy of PND for beta-thalassemia is crucial, particularly in regions with high prevalence, such as Khuzestan, Iran. Although the overall diagnostic error rate was low (2.14%), the consequences of such errors are significant. The diagnostic error can lead to the birth of affected children and an added burden on families and healthcare systems. Most errors were linked to point mutations and were more frequent in amniotic fluid sampling than in CVS. To minimize such diagnostic mistakes, advancements in molecular diagnostic techniques—especially for detecting rare mutations—are necessary.
Keywords: Beta-Thalassemia, Chorionic Villus Sampling, Diagnostic Error, Mutation, Prenatal Diagnosis
Type of Study: Research |
Subject:
Hematology
Received: 2025/01/3 | Accepted: 2025/09/7 | Published: 2025/09/19
Received: 2025/01/3 | Accepted: 2025/09/7 | Published: 2025/09/19
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
